The microbial lipase market was valued at USD 400.6 Million in 2017 and is projected to reach USD 590.2 Million by 2023, growing at a CAGR of 6.8% from 2018, in terms of value. The objectives of this study are to define, segment, and project the size of the microbial lipase market based on application, form, source, and key regions.
For more details on this research, Request Free Sample Report
- To understand the structure of the microbial lipase market by identifying its various subsegments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyze the micromarkets with respect to individual growth trends, future prospects, and their contribution to the total market
- To project the size of the market and its submarkets, in terms of value and volume, with respect to five regions (along with their respective key countries)
- To profile the key players and comprehensively analyze their core competencies
- To provide a comparative analysis of the market leaders on the basis of the following:
- Product offerings
- Business strategies
- Strengths and weaknesses
- Key financials
- To understand the competitive landscape and identifying major growth strategies adopted by the players across the key regions
- To analyze the competitive developments such as expansions, new product launches, mergers & acquisitions, agreements, partnerships, and investments in the market for microbial lipase.
The years and periodization considered for the study are as follows:
- Base year: 2017
- Beginning of the projection period: 2018
- End of the projection period: 2023
This report includes the estimation of the market size for value (USD million) and volume (metric tons). Both, top-down and bottom-up approaches have been used to estimate and validate the size of the microbial lipase market and to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research (FAO, Bloomberg Businessweek, Factiva, and companies’ annual reports), and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
To know about the assumptions considered for the study, download the pdf brochure
Market Ecosystem
The various contributors involved in the value chain of microbial lipases include manufacturers, suppliers, distributors, intermediaries, and customers. The key players in the microbial lipase market include Novozymes (Denmark), DSM (Netherlands), Chr. Hansen (Denmark), Amano Enzymes (Japan), Associated British Foods (UK), DowDuPont (US), Advanced Enzymes (India), Enzyme Development Corporation (US), Aumgene Biosciences (India), Biocatalysts (UK), Meito Sangyo Co., Ltd (Japan), and Creative Enzymes (US).
